[{"NetIncomeLoss_1_Q2_USD":-31167000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_2_Q2_USD":-11000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_1_Q2_USD":-6000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":1.006,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q2_pure":1.006,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-295000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":1192000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.012,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q2_pure":0.005,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":114804000.0,"PaymentsToAcquireInvestments_2_Q2_USD":129899000.0,"OtherAssets_0_Q2_USD":8778000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":4262000.0,"AssetsCurrent_0_Q2_USD":578761000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":800000.0,"DerivativeGainLossOnDerivativeNet_2_Q2_USD":-16796000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":9777731.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":2245000.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2159000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":2998000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":2932000.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_2_Q2_USD":400000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommitmentsAndContingencies_0_Q2_USD":null,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":206699000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":15177000.0,"ShareBasedCompensation_2_Q2_USD":8717000.0,"Assets_0_Q2_USD":672238000.0,"CommonStockSharesIssued_0_Q2_shares":117727086.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":4210000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":2388000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":114980652.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":111684283.0,"GeneralAndAdministrativeExpense_1_Q2_USD":16386000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":205425000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":2061000.0,"DepreciationDepletionAndAmortization_1_Q2_USD":1100000.0,"Revenues_1_Q2_USD":66988000.0,"Revenues_2_Q2_USD":72706000.0,"CommonStockValue_0_Q2_USD":12000.0,"DeferredRevenueNoncurrent_0_Q2_USD":3815000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":-4011000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":62000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-2895000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-9964000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":18832000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":79653000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":144632000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":46000.0,"OperatingIncomeLoss_2_Q2_USD":-100961000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":552400000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":38560000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":29035000.0,"MarketableSecuritiesCurrent_0_Q2_USD":180599000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OperatingLeaseLiability_0_Q2_USD":15900000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-549000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":295000.0,"ProceedsFromSaleOfPropertyHeldForSale_2_Q2_USD":180000.0,"Liabilities_0_Q2_USD":108459000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":12762000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":371781000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":612000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1342000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-31710000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-108101000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":247168000.0,"OperatingIncomeLoss_1_Q2_USD":-29051000.0,"InvestmentIncomeInterest_2_Q2_USD":2580000.0,"InvestmentIncomeInterest_1_Q2_USD":825000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.888,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":15357000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":383997000.0,"NonoperatingIncomeExpense_1_Q2_USD":-2070000.0,"NonoperatingIncomeExpense_2_Q2_USD":-7384000.0,"AccountsPayableCurrent_0_Q2_USD":4382000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q2_pure":0.957,"DeferredRevenueCurrent_0_Q2_USD":7298000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":4142000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":4700000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-59048000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":8717000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5750000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-31121000.0,"LiabilitiesCurrent_0_Q2_USD":54940000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-108345000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":2388000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":35082000.0,"NetIncomeLoss_2_Q2_USD":-108407000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":16311000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":30670000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":312000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":3305000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":595000.0,"OperatingLeasePayments_2_Q2_USD":2200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.004,"AdditionalPaidInCapital_0_Q2_USD":1040988000.0,"ShortTermLeaseCost_1_Q2_USD":162000.0,"ShortTermLeaseCost_2_Q2_USD":317000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":361000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.077,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q2_pure":0.004,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":2162000.0,"Goodwill_0_Q2_USD":16937000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-543000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":6791000.0,"OperatingExpenses_1_Q2_USD":96039000.0,"OperatingExpenses_2_Q2_USD":173667000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3138000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":23204000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q2_USD":462000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q2_USD":11024000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_2_Q2_USD":889000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":8717000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":672238000.0,"OperatingLeaseCost_1_Q2_USD":1141000.0,"OperatingLeaseCost_2_Q2_USD":2281000.0,"PreferredStockValue_0_Q2_USD":null,"AllocatedShareBasedCompensationExpense_1_Q2_USD":5750000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":11000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.97,"ProfitLoss_2_Q2_USD":-108407000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":306000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":6893000.0,"CommonStockSharesOutstanding_0_Q2_shares":117727086.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":261181000.0,"LeaseCost_1_Q2_USD":1949000.0,"LeaseCost_2_Q2_USD":3838000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.27,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-476926000.0,"VariableLeaseCost_2_Q2_USD":1240000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-818000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":2645000.0,"StockholdersEquity_0_Q2_USD":563779000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":244000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":2967000.0,"VariableLeaseCost_1_Q2_USD":646000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":2936000.0,"Ticker":"VIR","CIK":"1706431","name":"VIR BIOTECHNOLOGY, INC.","OfficialName":"Vir Biotechnology Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3076942595.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200811"}]